BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Moh-klaren J, Bodivit G, Jugie M, Chadebech P, Chevret L, Mokhtari M, Chamillard X, Gallon P, Tissières P, Bierling P, Djoudi R, Pirenne F, Burin-des-roziers N. Severe hemolysis after plasma transfusion in a neonate with necrotizing enterocolitis, Clostridium perfringens infection, and red blood cell T-polyagglutination: T-ANTIGEN ACTIVATION AND HEMOLYSIS IN NEC. Transfusion 2017;57:2571-7. [DOI: 10.1111/trf.14196] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 1.2] [Reference Citation Analysis]
Number Citing Articles
1 Roseff SD. Cryptantigens: time to uncover the real significance of T-activation: EDITORIAL. Transfusion 2017;57:2553-7. [DOI: 10.1111/trf.14366] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.4] [Reference Citation Analysis]
2 Jacquot C, Pary PP, Babu V, Belay E, Mo YD, Webb JL, Luban NLC, Delaney M. Erythrocyte T-antigen activation in children: Patient characteristics and the hemolytic risk of transfusion. Pediatr Blood Cancer 2021;68:e29082. [PMID: 33900685 DOI: 10.1002/pbc.29082] [Reference Citation Analysis]
3 Kurtenkov O. Profiling of Naturally Occurring Antibodies to the Thomsen-Friedenreich Antigen in Health and Cancer: The Diversity and Clinical Potential. Biomed Res Int 2020;2020:9747040. [PMID: 32280709 DOI: 10.1155/2020/9747040] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
4 Hsiao HH, Yeh CJ, Ting SC, Chuang TM, Ke YL, Yeh TJ, Gau YC, Du JS, Hsiao CE, Wang HC, Cho SF, Hsu CM, Liu YC. Is it reasonable for the use of Rh-ee blood? A hospital-based survey from a southern medical center in Taiwan. Kaohsiung J Med Sci 2021. [PMID: 34647681 DOI: 10.1002/kjm2.12453] [Reference Citation Analysis]